Table 3.
ADR group | Non-ADR group | Total | |
Number of admissions | 218 | 969 | 1187 |
Age, mean (SD) | 73.2 (14.5) | 66.7 (19.2) | 67.9 (18.6) |
Male (%) | 106 (48.6) | 455 (47.0) | 561 (47.3) |
Number of medicines, mean (SD) | 10.5 (4.6) | 7.8 (5.1) | 8.3 (5.1) |
Polypharmacy (%) | 199 (91.3) | 706 (72.9) | 905 (76.2) |
Number of comorbidities, mean (SD) | 6.1 (3.0) | 5.2 (3.3) | 5.4 (3.2) |
Multimorbid (%) | 99.1 | 90.3 | 91.9 |
Liver impairment* (%) | 6.9 | 2.8 | 3.5 |
Renal impairment† (%) | 11.0 | 6.8 | 7.6 |
*Liver impairment defined as chronic liver disease.
†Renal impairment defined as chronic kidney disease stage IV or V.